534 related articles for article (PubMed ID: 3753655)
1. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Cortés R; Probst A; Tobler HJ; Palacios JM
Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
Cortés R; Palacios JM
Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874
[TBL] [Abstract][Full Text] [Related]
3. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic localization of muscarinic cholinergic receptors in visual areas of cat brain: variations in sensitivity of N-[3H]methylscopolamine binding sites to carbachol and pirenzepine.
Cymerman U; Palacios JM; Cortés R; Skangiel-Kramska J
Neurosci Lett; 1987 Oct; 81(1-2):13-8. PubMed ID: 3696462
[TBL] [Abstract][Full Text] [Related]
5. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
6. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
7. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
Smith TD; Annis SJ; Ehlert FJ; Leslie FM
J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
[TBL] [Abstract][Full Text] [Related]
8. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
Watson M; Yamamura HI; Roeske WR
Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
Gillard M; Waelbroeck M; Christophe J
J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
[TBL] [Abstract][Full Text] [Related]
10. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
12. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain.
Cortés R; Probst A; Palacios JM
Neuroscience; 1987 Jan; 20(1):65-107. PubMed ID: 3561769
[TBL] [Abstract][Full Text] [Related]
13. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture.
Alonso R; Didier M; Soubrie P
J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor subtypes in human and rat colon smooth muscle.
Gómez A; Martos F; Bellido I; Marquez E; Garcia AJ; Pavia J; Sanchez de la Cuesta F
Biochem Pharmacol; 1992 Jun; 43(11):2413-9. PubMed ID: 1610405
[TBL] [Abstract][Full Text] [Related]
15. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptors in isolated gastric fundic mucosal cells. Binding-activity relationships.
Magous R; Baudiere B; Bali JP
Biochem Pharmacol; 1985 Jul; 34(13):2269-74. PubMed ID: 3839398
[TBL] [Abstract][Full Text] [Related]
17. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologically defined M1 and M2 muscarinic cholinergic binding sites in the cat's substantia nigra: development and maturity.
Nastuk MA; Graybiel AM
Brain Res Dev Brain Res; 1991 Jul; 61(1):1-10. PubMed ID: 1914150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
